Abstract
Objective
NADPH oxidase is potentially associated with acute pancreatitis by producing reactive oxygen species (ROS). We investigated whether NADPH oxidase mediates the activation of Janus kinase (Jak)2/signal transducers and activators of transcription (Stat)3 and mitogen-activated protein kinases (MAPKs) to induce the expression of transforming growth factor-β1 (TGF-β1) in cerulein-stimulated pancreatic acinar cells.
Treatment
AR42J cells were treated with an NADPH oxidase inhibitor diphenyleneiodonium (DPI) or a Jak2 inhibitor AG490. Other cells were transfected with antisense or sense oligonucleotides (AS or S ODNs) for NADPH oxidase subunit p22phox or p47phox.
Methods
TGF-β1 was determined by enzyme-linked immonosorbent assay. STAT3-DNA binding activity was measured by electrophoretic mobility shift assay. Levels of MAPKs as well as total and phospho-specific forms of Jak1/Stat3 were assessed by Western blot analysis.
Results
Cerulein induced increases in TGF-β1, Stat3-DNA binding activity and the activation of MAPKs in AR42J cells. AG490 suppressed these cerulein-induced changes, similar to inhibition by DPI. Cerulein-induced activation of Jak2/Stat3 and increases in MAPKs and TGF-β1 levels were inhibited in the cells transfected with AS ODN for p22phox and p47phox compared to S ODN controls.
Conclusion
Inhibition of NADPH oxidase may be beneficial for prevention and treatment of pancreatitis by suppressing Jak2/Stat3 and MAPKs and expression of TGF-β1 in pancreatic acinar cells.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Acute pancreatitis is a multifactorial disease that involves both local and systemic effects caused by the release of digestive enzymes into the pancreatic interstitium and systemic circulation, and by the production and release of cytokines [1–3]. High doses of cerulein, a cholecystokinin (CCK) analogue [4], result in experimental pancreatitis. Similar to human pancreatitis, experimental pancreatitis involves dysregulation of the production and secretion of digestive enzymes leading to an elevation in their serum levels, as well as cytoplasmic vacuolization, death of acinar cells and edema formation [5–7]. Transforming growth factor-β1 (TGF-β1) is known to be one of the cytokines that regulate extracellular matrix remodeling in the pancreas and is involved in the pathogenesis of pancreatic inflammation and fibrosis [8–11]. TGF-β1 eliminates the damaged acinar cells by promoting acinar apoptosis during acute pancreatitis induced by cerulein [12]. Inhibition of TGF-β1 not only alleviates pancreatic fibrosis but also protects the pancreas from chronic injury due to excessive apoptosis [13].
Reactive oxygen species (ROS) are regarded as the molecular triggers of various inflammatory responses including pancreatitis [14]. ROS attack biological membranes directly, triggering the accumulation of neutrophils and their adherence to the capillary wall [14]. ROS may thus play a critical role in perpetuating pancreatic inflammation and the development of extrapancreatic complications [15]. ROS activate nuclear factor-κB (NF-κB) and mitogen-activated protein kinases (MAPKs) which regulate the expression of inflammatory cytokines including interleukin (IL)-1β, IL-6 [16], IL-8 [17] and TGF-β1 [18] as well as substance P [19] in cerulein-stimulated pancreatic acinar cells. NADPH oxidase is activated by inflammatory stimuli and produces large amounts of ROS in phagocytic and non-phagocytic cells [20, 21]. In phagocytic cells, NADPH oxidase is composed of membrane-bound subunits gp91phox and p22phox, and separate cytosolic subunits p67phox and p47phox. Upon activation, a complex of the cytosolic subunits translocates to the membrane and facilitates NADPH-dependent formation of superoxide (O2 −) and other secondary ROS (H2O2). Several non-phagocytic cells, such as vascular endothelial cells and pulmonary and systemic smooth muscle cells, contain NADPH oxidase to produce toxic ROS [22]. Recently, we found that NADPH oxidase subunits Nox1, p27phox, p47phox and p67phox are present in pancreatic acinar AR42J cells and produce ROS upon cerulein stimulation [23]. The activation of MAPKs and NF-κB to induce the expression of cytokines [16–18] may therefore be mediated by ROS in cerulein-stimulated pancreatic acinar cells. However, the precise mechanism whereby activated NADPH oxidase induces inflammation in pancreatic acinar cells during pancreatitis remains unclear.
Several lines of evidence support the activation of MAPKs in cerulein-stimulated pancreatic acinar cells. Extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal protein kinase (JNK) and intracellular cAMP levels all modulate the expression of protein tyrosine phosphatases SHP-1 and SHP-2 in pancreas, and play an essential role in cerulein-induced acute pancreatitis [24]. Inhibition of JNK and ERK suppresses the expression of protein tyrosine phosphatase 1B which is increased in the early phase of acute cerulein-induced pancreatitis [25]. In addition, ERK, p38 and JNK are activated and cytokine (IL-1β, tumour necrosis factor [TNF]-α) concentrations are increased in pancreatic fragments stimulated with cerulein [26].
The Janus kinase (Jak)/signal transducers and activators of transcription (Stat) mediate the expression of inflammatory cytokines [27]. Jak/Stat signaling pathways function primarily through non-immune mediators such as growth factors, hormones and ROS, but also play a role in the immune response of various cytokines [27–29]. Jak2 and Stat1 proteins are expressed and activated by interferon (IFN)-γ in rat pancreatic acinar cells, perhaps contributing to cytokine secretion and stimulation of immune cells [30]. Since cerulein is a CCK analogue, it binds to the CCK receptor to activate signaling in pancreatic acinar cells. The CCK2 receptor is a Gq protein coupled receptor that mediates the activation of Jak2/Stat3 for cell proliferation in pancreatic tumor cells [31]. Previously, we showed that cerulein-activated Jak2/Stat3 induces the expression of IL-1β in pancreatic acinar cells [32]. AG490, a Jak2 inhibitor [33], reduced edema, vacuole formation and inflammatory cell infiltration induced by cerulein in vivo. Jak/Stat activation may therefore affect the development of acute pancreatitis by the induction of inflammatory mediators.
We hypothesized that NADPH oxidase may be involved in signaling pathways such as those of Jak2/Stat3 and MAPKs to induce inflammatory cytokines in cerulein-stimulated pancreatic acinar cells. Here we investigated the role of NADPH oxidase in inflammatory signaling and TGF-β1 induction in pancreatic acinar cells, to determine whether inhibition of the activation of NADPH oxidase is beneficial for the prevention and treatment of pancreatitis.
The present study aims to investigate whether NADPH oxidase mediates the activation of Jak2/Stat3 and MAPKs (ERK, JNK, p38) to induce the expression of TGF-β1 in cerulein-stimulated pancreatic acinar AR42J cells. Cells were treated with an NADPH oxidase inhibitor diphenyleneiodonium (DPI), or transfected with antisense oligonucleotides (AS ODN) or sense oligonucleotides (S ODN) for NADPH oxidase subunit p22phox or p47phox. The activation of Jak2/Stat3 and MAPKs, Stat3-DNA binding activity and the level of TGF-β1 in the medium were determined. In addition, to investigate the role of Jak2/Stat3 on the expression of TGF-β1, cells were treated with Jak2 inhibitor AG490. Stat3-DNA binding activity, MAPK activation and the level of TGF-β1 released into the medium were determined. Even though AG490 was developed as a Jak2 inhibitor [33], it also blocks Stat3 activation in some cancer cells [34, 35]. We therefore used AG490 to inhibit both Jak2 and Stat3.
Materials and methods
Cell culture condition
Rat pancreatic acinar cells (AR42J cells) were obtained from the American Type Culture Collection (Manassas, VA, USA). The cells were cultured in Dulbecco’s modified Eagle’s medium (Sigma, St. Louis, MO, USA) supplemented with 3.7 g/L sodium bicarbonate, 10% fetal bovine serum (Gibco-BRL, Grand Island, NY, USA), and 1% antibiotics (100 units/mL penicillin and 100 µg/mL streptomycin). Cells were used for experiments after incubation for 20–24 h at 37°C in a humidified atmosphere of 90% air, 10% CO2.
Experimental protocol
AR42J cells (5 × 105 cells per well in a 12-well plate) were stimulated with cerulein (10−8 M) for 24 h to assess the level of TGF-β1 in the medium, or for 30 min to assess the activation of Jak2/Stat3 and MAPKs, and Stat3-DNA binding activity. Cells were treated with DPI (10 μM) or AG490 (50 μM) for 2 h before stimulation with cerulein. The concentrations of cerulein, DPI and AG490 and the culture period were adapted from our previous studies [16, 17, 21, 32]. For knockdown experiments, cells were transfected with antisense oligonucleotides (AS ODN) or sense oligonucleotides (S ODN) (0.5 μM) for NADPH oxidase subunit p22phox or p47phox for 24 h before stimulation with cerulein.
Western blot analysis of total or phosphorylated Jak2, Stat3, ERK, JNK and p38
Cells were trypsinized, washed, and then homogenized in Tris–HCl (pH 7.4) buffer containing 1% NP-40 and protease inhibitor cocktail (Boehringer Mannheim, Indianapolis, IN, USA). The protein concentration of each sample was determined by Bradford assay (Bio-Rad Laboratories, Hercules, CA, USA). Total cell extracts (50 μg) were separated by 8% SDS polyacrylamide gel electrophoresis under reducing conditions and electroblotted onto nitrocellulose membranes (Amersham Inc., Arlington Heights, IL, USA). Membranes were blocked for 2 h with 5% nonfat dry milk and then incubated with polyclonal antibodies against Jak2 (1:500, sc-7229, Santa Cruz Biotechnology, Santa Cruz, CA, USA), Stat3 (1:500, Cat. No. 06–596, Upstate Biotechnology, Lake Placid, NY, USA), phospho-Jak2 (1:500, Cat. No. 3771, Cell Signaling, Beverly, MA, USA), and phospho-Stat3 (1:500, Cat. No. 9131, Cell Signaling) diluted in TBS-T (Tris-buffered saline and 0.15% Tween 20) containing 5% nonfat dry milk at 4°C overnight. For antibodies against MAPKs, polyclonal antibodies for pan-ERK1/2 (1:500, Cat. No. 3771, Cell Signaling), pan-JNK1/2 (1:500; sc-7345, Santa Cruz Biotechnology), pan-p38 (1:500, Cat. No. 9212, Cell Signaling), phospho- ERK1/2 (1:500; sc-7383, Santa Cruz Biotechnology), phospho-JNK (1:500; sc-6254, Santa Cruz Biotechnology) and phospho-p38 (1:500; sc-7975, Santa Cruz Biotechnology) were used. After washing with TBS-T, the immunoreactive proteins were visualized with enhanced chemiluminescence (Santa Cruz Biotechnology) using goat anti-rabbit secondary antibodies (1:2,000, Cat. No. sc-2004, Santa Cruz Biotechnology) conjugated to horseradish peroxidase.
Electrophoretic mobility shift assay (EMSA) for Stat3-DNA binding activity
EMSAs were carried out essentially as described by Dignam et al. [36]. Cells were rinsed with ice-cold phosphate buffered saline (PBS), harvested by scraping into PBS, and pelleted by centrifugation at 1,500 rpm for 5 min. The cells were extracted in buffer containing 10 mM HEPES, 10 mM KCl, 0.1 mM ethylenediaminetetraacetic acid (EDTA), 1.5 mM MgCl2, 0.2% Nonidet P-40, 1 mM dithiothreitol (DTT) and 0.5 mM phenylmethyl-sulfonyl fluoride (PMSF). After centrifugation at 13,000 rpm for 10 min, the nuclear pellet was resuspended on ice in a nuclear extraction buffer containing 20 mM HEPES, 420 mM NaCl, 0.1 mM EDTA, 1.5 mM MgCl2, 25% glycerol, 1 mM DTT and 0.5 mM PMSF. The protein concentrations of nuclear extracts were determined by Bradford assay (Bio-Rad Laboratories). A Stat3 EMSA oligonucleotide (5′-GATCCTTCTGGGAATTCCTAGATC-3′, Santa Cruz Biotechnology) was labeled with [32P]-dATP (Amersham) using T4 polynucleotide kinase (Gibco). The end-labeled probe was separated from unincorporated [32P]-dATP on a Bio-Rad purification column (Bio-Rad Laboratories) and recovered in Tris–EDTA buffer (TE). Nuclear extracts (3 μg) were incubated with the buffer containing 32P-labeled NF- κB consensus oligonucleotide for 30 min, and subjected to electrophoretic separation on a nondenaturing acrylamide gel. Gels were dried at 80°C for 2 h and exposed to radiography film for 6–18 h at −70°C with intensifying screens.
Enzyme-linked immunosorbent assay (ELISA)
Levels of TGF-β1 in the medium were determined by enzyme-linked immunosorbent assay kits (R&D System, Minneapolis, MN, USA) according to the manufacturer’s instructions.
Transfection with antisense or sense oligonucleotides
Phosphothioate-modified oligonucleotides (ODNs) were produced commercially (Gibco-BRL). The sequences of p22phox antisense (AS) and sense (S) ODNs were 5′-GATCTGCCCCATGGTGAGGACC-3′ and 5′-GGTCCTCACCATGGGGCAGATC-3′, respectively. The sequences of the p47phox AS and S ODNs were 5′-CTGTTGAAGTACTCGGTGAG-3′ and 5′-CTCACCGAGTACTTCAACAG-3′, respectively. ODNs were incubated with DOTAP transfection reagent (15 μg/ml, Boehringer-Mannheim) at final concentrations of 0.5 μM ODN, for 15 min. Cells were transfected with ODNs for 24 h before cerulein treatment (10−8 M).
Statistical analysis
Statistical differences were determined using one-way ANOVA and Newman–Keul’s test [37]. All values are expressed as mean ± SE of four different experiments.
Results
Cerulein-dependent increases in TGF-β1 levels, Stat3-DNA binding activity and MAPK activation are inhibited by AG490 in AR42J cells
We investigated the effects of cerulein on AR42J cells. Cerulein induced a time-dependent increase in TGF-β1 levels in the medium up to 24 h (Fig. 1a). Stat3-DNA binding activity and MAPK activation were also increased in cerulein-stimulated AR42J cells, evident at 30 min of culture (Figs. 1b, 2). To determine the inhibitory effect of AG490 on cerulein-induced changes, cells were therefore pretreated with AG490 for 2 h, and then cultured in the presence of cerulein for either 24 h to measure TGF-β1 levels, or for 30 min to assay Stat3-DNA binding activity and the activation of MAPKs (ERK, JNK, p38). The cerulein-induced increases in TGF-β1 levels and Stat3-DNA binding activity were inhibited by pretreatment of AR42J cells with AG490 (Fig. 3). Since AG490 inhibits Jak2 and Stat3 in cerulein-stimulated pancreatic acinar cells [32], the results suggested that TGF-β1 expression was mediated by the activation of Jak2 and Stat3. AG490 also inhibited the activation of MAPKs in cerulein-stimulated AR42J cells, demonstrating that Jak2/Stat3 signaling was upstream of MAPK activation in cerulein-stimulated pancreatic acinar cells (Fig. 4). Total levels of ERK, JNK and p38 were not changed by cerulein treatment, with or without AG490 (Fig. 4).
Cerulein-induced activation of Jak2/Stat3 and MAPKs and increase in Stat3-DNA binding activity and expression of TGF-β1 are inhibited by DPI and by transfection with AS ODNs for p22phox and p47phox in AR42J cells
DPI treatment was found to inhibit the cerulein-induced activation of MAPKs in AR42J cells at 30 min of culture (Fig. 4). In addition, DPI suppressed the phosphorylation of Jak2 and Stat3 as well as Stat3-DNA binding activity without altering the total levels of Jak2 and Stat3 proteins (Fig. 5a, b). Cerulein-induced TGF-β1 expression was inhibited by DPI at 24 h of culture (Fig. 5c). AS ODNs for NADPH oxidase subunits p22phox and p47phox were also found to inhibit the cerulein-induced activation of Jak2 and Stat3, the increase in Stat3-DNA binding activity, and the activation of MAPKs, compared to the corresponding S ODNs (Figs. 6, 7). In addition, transfection with AS ODNs for p22phox and p47phox inhibited cerulein-induced TGF-β1 expression (Fig. 8). Total levels of MAPKs (ERK, JNK and p38) (Fig. 4a), Jak2 and Stat3 (Fig. 5a) were not changed by cerulein treatment with or without DPI. Transfection with AS ODNs for NADPH oxidase subunits did not affect the levels of total Jak2 and Stat3 (Fig. 6a) as well as MAPKs (Fig. 7b) in AR42J cells stimulated with cerulein. These results demonstrate that inhibition of NADPH oxidase by DPI and transfection with AS ODNs for NADPH oxidase subunits suppressed both cerulein-induced activation of Jak2/Stat3 and MAPKs, and cerulein-induced TGF-β1 expression.
Discussion
ROS play a key regulatory role in the pathogenesis of pancreatitis [14], suggesting that their production represents an important target for preventing and treating pancreatitis. Previously, we found that NADPH oxidase subunits are expressed in pancreatic acinar cells [22]. Cerulein, which induces experimental pancreatitis, leads to translocation of the p47phox and p67phox subunits to the membrane and activates NADPH oxidase, which is inhibited by DPI [22]. If NADPH oxidase mediates inflammatory signaling such as pathways involving MAPKs and Jak/Stat to induce inflammatory cytokine expression, inhibition of NADPH oxidase would be the first step to suppressing the propagation of inflammation in pancreas.
The Jak/Stat pathway mediates a wide variety of biological effects including immune responses, differentiation, cell survival, proliferation and oncogenesis [38]. Binding of cytokines to cytokine receptors induces oligomerization of the receptor subunits, constitutive binding to Jak, and trans-phosphorylation of tyrosine kinases. Activated Jaks in turn phosphorylate the receptor that recruits the Stat protein [38]. In addition to the interaction of cytokines with their receptors, Jak2 can also be activated by ROS [39]. Here we showed that inhibition of NADPH oxidase suppressed cerulein-induced activation of Jak2/Stat3. Irrespective of whether ROS inhibit protein tyrosine phosphatase, thereby inducing tyrosine phosphorylation of Jak as previously reported [40], our findings clearly show that inhibition of NADPH oxidase suppresses the activation of Jak2/Stat3 and Stat3-DNA binding as well as the expression of TGF-β1 in cerulein-stimulated AR42J cells.
In addition to ROS, both JNK and ERK modulate the expression of protein tyrosine phosphatases in pancreas [24]. Inhibition of JNK and ERK suppresses the expression of protein tyrosine phosphatase 1B which is increased in the early phase of cerulein-induced acute pancreatitis [25]. In addition, pancreatic fragments stimulated with cerulein show activation of ERK, p38 and JNK and increased levels of cytokines (IL-1β, TNF-α) [26]. These studies related ROS, the activation of MAPKs, and cytokine expression in pancreatic acinar cells stimulated with cerulein.
In this study, we found that AG490 inhibited cerulein-induced activation of Jak2/Stat3 and MAPKs, and the expression of TGF-β1 in pancreatic acinar cells. We previously demonstrated that AG490 inhibits the activation of both Jak2 and Stat3 in cerulein-stimulated pancreatic acinar cells [32]. AG490 inhibits leukemic cell growth [33] and growth of mycosis fungoides tumor cells [34] by blocking Jak2 and Stat3. Therefore, the activation of both Jak2 and Stat3 appears to be involved in the expression of TGF-β1 in cerulein-stimulated pancreatic acinar cells. In the present study, cerulein-induced activation of MAPKs (ERK, JNK and p38) was suppressed by treatment with AG490 and DPI or by transfection with AS ODN for p22phox or p47phox in AR42J cells. The results demonstrate that cerulein-induced activation of Jak2/Stat3 may be upstream signaling of MAPK activation in pancreatic acinar cells. It is evident that ROS produced by NADPH oxidase mediate the activation of both MAPKs and Jak2/Stat3 in pancreatic acinar cells stimulated with cerulein, which induces the expression of inflammatory cytokines such as TGF-β1 and thus may contribute to pancreatic inflammation.
DPI is a noncompetitive inhibitor of NADPH oxidase that acts by binding covalently to FAD when the enzyme is activated [41]. Although DPI is a nonspecific inhibitor of flavoenzymes, the decrease of cellular production of ROS in the presence of DPI has increasingly been recognized as a result of its inhibition of NADPH oxidase [42]. DPI not only inhibits flavoenzymes, but also reversibly blocks K+ and Ca2+ currents [43, 44], thus affecting cell cycle-mediated cell proliferation [45, 46]. Thus, inhibition of NADPH oxidase may not be the sole mechanism of the effect of DPI on TGF-β1 expression. We found that the activation of Jak2/Stat3 was similarly suppressed by either transfection of an AS ODN for NADPH oxidase subunits or treatment with DPI, but TGF-β1 induction was more strongly inhibited by transfection of an AS ODN for NADPH oxidase subunits. While it is clear that inhibition of ROS production by suppression of NADPH oxidase decreases the activation of Jak2/Stat3 in pancreatic acinar cells, DPI may also affect signaling downstream of Jak2/Stat3 to induce TGF-β1. Further study will be required to elucidate the precise inhibitory mechanism of DPI in this system.
In addition to Jak2/Stat3, the oxidant-sensitive nuclear transcription factor NF-κB is also activated by ROS [47]. NF-κB activation by ROS was not observed in HeLa cells, fibroblasts or Jurkat T cells [48, 49], suggesting that ROS-induced NF-κB activation may be highly cell type-specific. We previously found that AG490 inhibited the activation of NF-κB in cerulein-stimulated pancreatic acinar AR42J cells (data not shown). NF-κB signaling thus appears to be directly regulated by Jak2/Stat3 activation in AR42J cells, consistent with previous reports of Jak-mediated NF-κB activation [50]. Jak signaling in turn mediates ERK activation, since chemical inhibition of Jak activation suppresses phosphorylation of ERK [51].
Here we used the pancreatic acinar AR42J cell line instead of freshly isolated and dispersed pancreatic acini to investigate the role of NADPH oxidase on activation of Jak2/Stat3 and TGF-β1 expression. To inhibit NADPH oxidase activation, the cells were transfected with AS ODNs for NADPH oxidase subunits, since there is no specific inhibitor for NADHP oxidase. The commonly used NADPH oxidase inhibitor DPI is a non-specific inhibitor [52]. In addition, AR42J cells were more efficiently transfected with AS ODNs than dispersed pancreatic acini in our preliminary experiments (unpublished data). AR42J is the only currently available cell line that maintains many characteristics of normal pancreatic acinar cells, such as the synthesis and secretion of digestive enzymes [53]. AR42J cell receptor expression and signal transduction mechanisms parallel those of pancreatic acinar cells. This cell line has been widely used as an in vitro model to study cellular secretion, growth, proliferation and apoptosis of the exocrine pancreas [53–56], making it an ideal model for our study. However, further studies using experimental animals with pancreatitis should be performed to determine the direct involvement and action mechanism of NADPH oxidase on the activation of Jak2/Stat3, MAPKs and TGF-β1 expression in the pathogenesis of pancreatitis.
In conclusion, cerulein-induced activation of NADPH oxidase may trigger the activation of Jak2/Stat3, resulting in several important inflammatory events in pancreas, including Stat3-DNA binding and the production of inflammatory cytokines such as TGF-β1. Jak2/Stat3 signaling acts upstream of the activation of MAPKs (ERK, JNK, p38) in cerulein-stimulated pancreatic acinar cells. Jak2/Stat3 activation may be one of the important molecular mechanisms underlying the pathogenesis of pancreatitis. Therefore, inhibition of the activation of NADPH oxidase may be beneficial for the prevention and treatment of pancreatitis by suppressing inflammatory signaling of Jak2/Stat3 and MAPKs and inhibiting the expression of TGF-β1 in pancreatic acinar cells.
References
Schoenberg MH, Büchler M, Gaspar M, Stinner A, Younes M, Melzner I, Bültmann B, Beger HG. Oxygen free radicals in acute pancreatitis of the rat. Gut. 1990;31:1138–43.
Petrone WF, English DK, Wong K, McCord JM. Free radicals and inflammation: superoxide dependent activation of a neutrophil chemotactic factor in plasma. Proc Natl Acad Sci USA. 1980;77:1159–63.
Wisner J, Green DF, Renner I. Evidence for a role of oxygen derived free radicals in the pathogenesis of cerulein induced acute pancreatic in rat. Gut. 1988;29:1516–23.
Hofbauer B, Saluja AK, Lerch MM, Bhagat L, Bhatia M, Lee HS, Frossard JL, Adler G, Steer ML. Intra-acinar cell activation of trypsinogen during cerulein-induced pancreatitis in rat. Am J Physiol. 1998;275:G352–62.
Lerch MM, Adler G. Experimental animal model of acute pancreatitis. Int J Pancreatol. 1994;15:159–70.
Willemer S, Elasser HP, Alder G. Hormone-induced pancreatitis. Eur Surg Res. 1992;24(Suppl 1):29–39.
Willwmer S, Adler G. Mechanism of acute pancreatitis. Cellular and subcellular events. Int J Pancreatol. 1991;9:21–30.
Muller-Pillasch F, Menke A, Yamaguchi H, Elsasser HP, Bachem M, Adler G, Gress TM. TGF-beta and the extracellular matrix in pancreatitis. Hepatogastroenterology. 1999;46:2751–6.
Shek FW, Benyon RC, Walker FM, McCrudden PR, Pender SL, Williams EJ, Johnson PA, Johnson CD, Bateman AC, Fine DR, Iredale JP. Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis. Am J Pathol. 2002;160:1787–98.
Ottaviano AJ, Sun L, Ananthanrayanan V, Munshi HG. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1. Cancer Res. 2006;66:7032–40.
Yoshikawa H, Kihara Y, Taguchi M, Yamaguchi T, Nakamura H, Otsuki M. Role of TGF-beta1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol. 2002;282:G549–58.
Lugea A, Nan L, French SW, Bezerra JA, Gukovskaya AS, Pandol SJ. Pancreas recovery following cerulein-induced pancreatitis is impaired in plasminogen-deficient mice. Gastroenterology. 2006;131:885–99.
Nagashio Y, Ueno H, Imamura M, Asaumi H, Watanabe S, Yamaguchi T, Taguchi M, Tashiro M, Otsuki M. Inhibition of transforming growth factor beta decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice. Lab Invest. 2004;84:1610–8.
Bjork J, Arfors KE. Oxygen free radicals and leukotriene B4 induced increase in vascular leakage is mediated by polymorphonuclear leukocytes. Agents Actions Suppl. 1982;11:63–72.
Guice KS, Oldham KT, Caty MG, Johnson KJ, Ward PA. Neutrophil-dependent, oxygen-radical mediated lung injury associated with acute pancreatitis. Ann Surg. 1989;210:740–7.
Yu JH, Lim JW, Namkung W, Kim H, Kim KH. Suppression of cerulein-induced cytokine expression by antioxidants in pancreatic acinar cells. Lab Invest. 2002;82:1359–68.
Ju KD, Yu JH, Kim H, Kim KH. Role of mitogen-activated protein kinases, NF-κB, and AP-1 on cerulein-induced IL-8 expression in pancreatic aincar cells. Ann NY Acad Sci. 2006;1090:368–74.
Babu BI, Malleo G, Genovese T, Mazzon E, Di Paola R, Crisafulli C, Caminiti R, Siriwardena AK, Cuzzocrea S. Green tea polyphenols ameliorate pancreatic injury in cerulein-induced murine acute pancreatitis. Pancreas. 2009;38(8):954–67.
Koh YH, Tamizhselvi R, Bhatia M. Extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator protein-1, contribute to cerulein-induced expression of substance P and neurokinin-1 receptors in pancreatic acinar cells. J Pharmacol Exp Ther. 2010;332(3):940–8.
Hiraoka W, Vazquez N, Nieves-Neira W, Nieves-Neira W, Chanock SJ, Pommier Y. Role of oxygen radicals generated by NADPH oxidase in apoptosis induced in human leukemia cells. J Clin Invest. 1998;102:1961–8.
Arroyo A, Modrianský M, Serinkan FB, Bello RI, Matsura T, Jiang J, Tyurin VA, Tyurina YY, Fadeel B, Kagan VE. NADPH oxidase-dependent oxidation and externalization of phosphatidylserine during apoptosis in Me2SO-differentiated HL-60 cells. Role in phagocytic clearance. J Biol Chem. 2002;277:49965–75.
Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494–501.
Yu JH, Lim JW, Kim H, Kim KH. NADPH oxidase mediates interukin-6 expression in cerulein-stimulated pancreatic acinar cells. Int J Biochem Cell Biol. 2005;37:1458–69.
Sarmiento N, Sánchez-Bernal C, Ayra M, Pérez N, Hernández-Hernández A, Calvo JJ, Sánchez-Yagüe J. Changes in the expression and dynamics of SHP-1 and SHP-2 during cerulein-induced acute pancreatitis in rats. Biochim Biophys Acta. 2008;1782(4):271–9.
Sarmiento N, Sánchez-Bernal C, Pérez N, Sardina JL, Mangas A, Calvo JJ, Sánchez-Yagüe J. Rolipram and SP600125 suppress the early increase in PTP1B expression during cerulein-induced pancreatitis in rats. Pancreas. 2010;39(5):639–45.
Samuel I, Zaheer A, Fisher RA. In vitro evidence for role of ERK, p38, and JNK in exocrine pancreatic cytokine production. J Gastrointest Surg. 2006;10(10):1376–83.
Liu KD, Gaffen SL, Goldsmith MA. JAK/STAT signaling by cytokine receptors. Curr Opin Immunol. 1998;10:271–8.
Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415–21.
Carballo M, Conde M, El Bekay R, Martín-Nieto J, Camacho MJ, Monteseirín J, Conde J, Bedoya FJ, Sobrino F. Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem. 1999;274:17580–6.
Gallmeier E, Schäfer C, Moubarak P, Tietz A, Plössl I, Huss R, Göke B, Wagner AC. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells. J Cell Physiol. 2005;203(1):209–16.
Ferrand A, Kowaski-Chauvel A, Bertrand C, Escrieut C, Mathieu A, Portolan G, Pradayrol L, Fourmy D, Dufresne M, Seva C. A novel mechanism for Jak2 activation by a G protein-coupled receptor, the CCK2R. J Biol Chem. 2005;280:10710–5.
Yu JH, Kim KH, Kim H. Suppression of IL-1β expression by the Jak2 inhibitor AG490 in cerulein-stimulated pancreatic acinar cells. Biochem Pharmacol. 2006;72:1555–62.
Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A, Roifman CM. Inhibition of acute lymphoblastic leukemia by a Jak2 inhibitor. Nature. 1996;379:645–8.
Nielsen M, Kaltoft K, Nordahl M, Röpke C, Geisler C, Mustelin T, Dobson P, Svejgaard A, Odum N. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci USA. 1997;94:6764–9.
Burdelya L, Catlett-Falcone R, Levitzki A, Cheng F, Mora LB, Sotomayor E, Coppola D, Sun J, Sebti S, Dalton WS, Jove R, Yu H. Combination therapy with AG-490 and interleukin 12 achieves greater antitumor effects than either agent alone. Mol Cancer Ther. 2002;1:893–9.
Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11:1475–89.
Tallarida RJ, Murray RB. Manual of pharmacological calculations with computer programs. New York: Springer; 1987. p. 121–5.
Rawlings JS, Rosler KM, Harrison DA. The JAK/STAT signaling pathway. J Cell Sci. 2004;117:1281–3.
Simon AR, Rai U, Fanburg BL, Cochran BH. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol. 1998;275:C1640–52.
Barrett WC, DeGnore JP, Konig S, Fales HM, Keng YF, Zhang ZY, Yim MB, Chock PB. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry. 1999;38:6699–705.
Jones RD, Hancock JT, Morice AH. NADPH oxidase: a universal oxygen sensor? Free Radic Biol Med. 2000;29:416–24.
Suzuki Y, Ono Y, Hirabayashi Y. Rapid and specific reactive oxygen species generation via NADPH oxidase activation during Fas-mediated apoptosis. FEBS Lett. 1998;425:209–12.
Wyatt CN, Weir EK, Peers C. Diphenyleneiodonium blocks K+ and Ca2+ currents in type I cells isolated from the neonatal rat carotid body. Neurosci Lett. 1994;172:63–6.
Weir EK, Wyatt CN, Reeve HL, Huang J, Archer SL, Peers C. Diphenyleneiodonium inhibits both potassium and calcium currents in isolated pulmonary artery smooth muscle cells. J Appl Physiol. 1994;76:2611–5.
Menon SG, Sarsour EH, Spitz DR, Higashikubo R, Sturm M, Zhang H, Goswami PC. Redox regulation of the G1 to S phase transition in the mouse embryo fibroblast cell cycle. Cancer Res. 2003;63:2109–17.
Scaife RM. G2 cell cycle arrest, down-regulation of cyclin B and induction of mitotic castrophe by the flavoprotein inhibitor diphenyleneiodonium. Mol Cancer Ther. 2004;3:1229–37.
Li N, Karin M. Is NF-κB the sensor of oxidative stress? FASEB J. 1999;13:1137–43.
Anderson MT, Staal FJ, Gitler C, Herzenberg LA, Herzenberg LA. Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc Natl Acad Sci USA. 1994;91:11527–31.
Brennan P, O’Neill LA. Effects of oxidants and antioxidants on nuclear factor kappa B activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim Biophys Acta. 1995;1260:167–75.
Samanta AK, Lin H, Kantarjian STH, Arlinghaus RB. Janus kinase 2: a critical target in chronic myelogenous leukemia. Cancer Res. 2006;66:6468–72.
Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D, Anania FA. Concomitant activation of the JAK/STAT, PI3 K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res. 2007;67:2497–507.
Li Y, Trush MA. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Comm. 1998;253:295–9.
Christophe J. Pancreatic tumoral cell line AR42J: an amphicrine model. Am J Physiol. 1994;266:G963–71.
Piiper A, Leser J, Lutz MP, Beil M, Zenzem S. Subcellular distribution and function of Rab3A-D in pancreatic acinar AR42J cells. Biochem Biophys Res Commun. 2001;287:746–51.
Sata N, Klonowski-Stumpe H, Han B, Luthen R, Haussinger D, Niederau C. Cytotoxicity of peroxynitrite in rat pancreatic acinar AR42J cells. Pancreas. 1997;15:278–84.
Masamune A, Sasaki Y, Satoh A, Fujita M, Yoshida M, Shimosegawa T. Lysophosphatidylcholine induces apoptosis in AR42J cells. Pancreas. 2001;22:75–83.
Acknowledgments
This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0001669) and a grant (Joint Research Project under the Korea-Japan Basic Scientific Cooperation Program) from NRF (F01-2009-000-10101-0). H. Kim is grateful to Brain Korea 21 Project, College of Human Ecology, Yonsei University.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible Editor: Liwu Li.
Rights and permissions
About this article
Cite this article
Ju, K.D., Lim, J.W., Kim, K.H. et al. Potential role of NADPH oxidase-mediated activation of Jak2/Stat3 and mitogen-activated protein kinases and expression of TGF-β1 in the pathophysiology of acute pancreatitis. Inflamm. Res. 60, 791–800 (2011). https://doi.org/10.1007/s00011-011-0335-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-011-0335-4